ijms-logo

Journal Browser

Journal Browser

Tumor Specific Immunotherapeutic Targets

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 January 2025 | Viewed by 61

Special Issue Editor


E-Mail Website
Guest Editor
COMT—Centre for Molecular and Translational Oncology, University of Parma, 43124 Parma, Italy
Interests: extracellular matrix; proteoglycans; immunotherapy; metastasis; angiogenesis; cell-matrix interactions; cancer stem cells; cell migration/invasion; tumour microenvironment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The disclosure of ideal targets for passive immunotherapy directed against the cancer cells of solid and hematologic tumours or their microenvironment (i.e., the tumour ecosystem) is challenging due to the difficulty in unveiling discrete molecules that are truly exclusive components of the tumour lesion. In hematologic neoplasia, this difficulty is further exacerbated by the need to target surface-associated antigens that are electively expressed by neoplastic lymphocytes/leukocytes.

Although most immunotherapeutics that are currently clinically approved for cancer treatment target fairly ubiquitous surface molecules, and their anti-tumour efficacy relies on their exuberant expression compared to that found on healthy cells, a recurrent clinical caveat is the high levels of collateral toxicity detected in patients over the years (post-treatment). This limitation incites the search for truly tumour-specific antigens that could serve the development of effective antibody drugs.

Multi-omics approaches and the creation of publicly accessible data bases compiling information derived from these approaches are affording a formidable opportunity to uncover highly selective cancer markers. This Special Issue seeks original manuscripts, classical reviews, perspectives discussing recently published findings, and well-circumstantiated hypothesis articles treating novel and previously identified immunotherapeutic targets, novel methods and technologies to identify them and/or ways to demonstrate the predicted efficacy. Provided that they are fully compatible with the scope of the Special Issue, contributions from computational science, physics and bioengineering fields are welcome.

Prof. Dr. Roberto Perris
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunotherapy
  • immunotherapeutics
  • tumour-specific antigens
  • immunotherapeutic targets
  • multi-omics approaches

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop